Quality Cancer Care Focused on You

Upon recently completing its Commission on Cancer (CoC) survey and accreditation site visit, Penn State Hershey Cancer Institute achieved full accreditation with gold level commendation status for three years from the American College of Surgeons. This recognition highlights the Cancer Institute's membership in an elite group of cancer programs committed to providing high-quality cancer care to patients in central Pennsylvania and beyond. It underscores the team's commitment to excellence and plays an important role in advancing its mission to improve lives.

You are Receiving Care from a CoC-accredited Program

The CoC recognizes Penn State Hershey's CoC-accredited cancer program for its voluntary commitment to providing high-quality, patient-centered care. As a CoC-accredited cancer program, the Cancer Institute demonstrates an important commitment to providing all patients with access to services they need from diagnoses through treatment, rehabilitation, and survivorship care.

The American College of Surgeons Commission on Cancer (CoC) represents the leaders in cancer care and partners with more than 50 organizations, including the American Cancer Society and LIVESTRONG, on patient-centered initiatives. It is dedicated to improving survival and quality of life for cancer patients through standard-setting, prevention, research, education, and the monitoring of comprehensive quality care.

Interested in Learning More?

More than 70 percent of patients with cancer in the U.S. receive patient-centered care from CoC-accredited cancer programs. For more information about the CoC, visit www.facs.org/cancer.

About Us

The region’s only comprehensive cancer center, with access to internationally recognized cancer specialists and scientists delivering a multidisciplinary approach to cancer care, patient friendly facilities, and up-to-date medical technology. First in the region to offer RapidArc™ radiotherapy technology, a breakthrough in radiation treatment.

Catchment area includes 27 counties, many of them medically underserved. The Cancer Institute is a regional coordinator for the 13-county South Central Pennsylvania Cancer Education Network as selected by the Pennsylvania Department of Health. The Institute provides cancer screening to medically underserved, at-risk individuals; increases cancer knowledge and awareness of health intervention participants; and facilitates community changes that support a healthy environment.

Physicians and researchers are at the forefront of personalized cancer care to prevent and treat cancer with as few side  effects as possible, including personalized risk assessment and counseling, genetic and technological screening for cancer, personalized monitoring and dosing of chemotherapy. New drugs have been discovered and are being developed for clinical testing against the most difficult-to-treat, aggressive, and resistant cancers. Unique clinical trials are available for patients with either early stage or advanced cancer.

A Blue Distinction Center for Complex and Rare Cancers by Highmark Blue Shield, which designates the institute as a facility within Highmark’s service area that offers comprehensive inpatient cancer care programs for adults delivered by multidisciplinary teams with subspecialty training, and distinguished clinical expertise in treating complex and rare subtypes of cancer.